Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea | MicrobiomeTrials← Back to trialsNCT07606820
Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2026-05-20Est. Completion: 2026-10-30
Enrollment target: 60 participants Locations- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, Nanjing, Jiangsu, China
Other microbiome trials you might be interested in
Facial Rosacea
This study aimed to evaluate the efficacy, tolerability, and safety of Eucerin Skin Relief Multi-Repair Cream containing…
Shanghai, ChinaEst. completion Jul 9, 2026
Rosacea
The skin and gut microbiome of rosacea patients differs from individuals without rosacea and that the microbiome suffers…
Baltimore, United StatesEst. completion Sep 2027